<DOC>
	<DOCNO>NCT01451463</DOCNO>
	<brief_summary>In individual Huntington 's disease ( HD ) , chorea may contribute balance problem difficulty walk , sit stand transfer stair climb turn may contribute high fall rate . Xenazine ( tetrabenazine ) monoamine-depleting drug commonly use reduce chorea . The purpose study compare : 1 ) spatial temporal gait measure , 2 ) performance functional mobility measure , 3 ) amount daily walking activity administration Xenazine individual HD . It hypothesize use Xenazine decrease chorea improve function 1 ) gait , 2 ) sit-to-stand transfer 3 ) stair climb 4 ) overall daily physical activity function .</brief_summary>
	<brief_title>Impact Xenazine ( Tetrabenazine ) Gait Functional Activity Individuals With Huntington 's Disease</brief_title>
	<detailed_description>Individuals HD ambulatory either already take Xenazine newly prescribe medication recruit prospective open-label study . A variety motor assessment preform subject take Xenazine period medication . These test include : Unified Huntington 's Disease Rating Scale ( UHDRS ) motor section , GAITRite forward walking , Tinetti Mobility Test , Timed Sit-to-Stand Test , Timed Stair Climb Test , Rhomberg test . A subset subject wear activity monitoring device wrist non-dominant hand 5 consecutive day night .</detailed_description>
	<mesh_term>Huntington Disease</mesh_term>
	<mesh_term>Tetrabenazine</mesh_term>
	<criteria>Huntington 's Disease Able ambulate independently Other orthopedic neurological disorder affect gait balance Pregnancy Chorea score &lt; 10 prior initiation medication . Inability provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Huntington 's Disease</keyword>
	<keyword>Chorea</keyword>
	<keyword>Gait</keyword>
	<keyword>Balance</keyword>
</DOC>